Cite

HARVARD Citation

    Vande Casteele, N. et al. (2012). Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment. Gut. 61 (2), p. 321. [Online]. 
  
Back to record